Literature DB >> 7861220

Interstitial radiosurgery of low-grade gliomas.

F W Kreth1, M Faist, P C Warnke, R Rossner, B Volk, C B Ostertag.   

Abstract

The treatment of patients with low-grade gliomas remains a subject of controversy, especially with respect to new treatment modalities such as interstitial radiosurgery (brachytherapy), radiosurgery, and stereotactic radiotherapy. In a retrospective analysis conducted between 1979 and 1991, the authors studied the results of interstitial radiosurgery in 455 patients with low-grade gliomas (World Health Organization (WHO) Grade I+WHO Grade II) with regard to survival time, quality of life, the risk of malignant transformation, and the risk profile of the treatment concept. Interstitial radiosurgery with iodine-125 was performed using permanent (1979-1985) or temporary implants (after 1985) with low-dose rates (< or = 10 cGy/hr) and a reference dose of 60 to 100 Gy calculated to the outer rim of the tumor. The 5- and 10-year survival rates in patients with pilocytic astrocytomas (97 patients) were 84.9% and 83%, and in patients with WHO Grade II astrocytomas (250 patients) 61% and 51%, respectively. Five-year survival rates for patients with oligoastrocytomas (60 patients), oligodendrogliomas (27 patients), and gemistocytic astrocytomas (21 patients) were 49%, 50%, and 32%, respectively. In the group with WHO Grade II gliomas, young age and a good performance status were associated with a better prognosis. Unfavorable factors were midline shift, enhancement on computerized tomography (CT) scan, and tumor recurrence after previous radiotherapy or surgery. Tumor location had no influence on the prognosis (247 patients in this series had deep-seated tumors). Malignant transformation was the major cause of death. Important risk factors for malignancy were the patient's age, tumor enhancement in CT scan, and tumor recurrence after previous surgery or radiotherapy. Perioperative mortality was 0.9% and perioperative morbidity was 1.7%. Radiogenic complications were observed in 2.7% of all patients, most often in larger tumors and after using permanent implants. The authors conclude that interstitial radiosurgery represents a specific treatment modality for selected patients with unifocal circumscribed low-grade gliomas with a diameter of less than 4 cm in any location. The efficacy of this treatment lies in the same range as the best results after surgery and radiotherapy.

Entities:  

Mesh:

Year:  1995        PMID: 7861220     DOI: 10.3171/jns.1995.82.3.0418

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  22 in total

Review 1.  Radiation therapy for incompletely resected supratentorial low-grade glioma in adults.

Authors:  B Jeremic; M Bamberg
Journal:  J Neurooncol       Date:  2001-11       Impact factor: 4.130

2.  Interstitial iodine-125 radiosurgery alone or in combination with microsurgery for pediatric patients with eloquently located low-grade glioma: a pilot study.

Authors:  A Peraud; C Goetz; A Siefert; J C Tonn; F W Kreth
Journal:  Childs Nerv Syst       Date:  2006-09-14       Impact factor: 1.475

3.  Vascular endothelial growth factor (VEGF) in astrocytic gliomas--a prognostic factor?

Authors:  R D Oehring; M Miletic; M M Valter; T Pietsch; J Neumann; R Fimmers; U Schlegel
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

4.  Natural history and management of low-grade glioma in NF-1 children.

Authors:  Pablo Hernáiz Driever; Stephan von Hornstein; Torsten Pietsch; Rolf Kortmann; Monika Warmuth-Metz; Angela Emser; Astrid K Gnekow
Journal:  J Neurooncol       Date:  2010-03-30       Impact factor: 4.130

5.  Prognostic relevance of gemistocytic grade II astrocytoma: gemistocytic component and MR imaging features compared to non-gemistocytic grade II astrocytoma.

Authors:  Young Jin Heo; Ji Eun Park; Ho Sung Kim; Ji Ye Lee; Soo Jeong Nam; Seung Chai Jung; Choong Gon Choi; Sang Joon Kim
Journal:  Eur Radiol       Date:  2016-11-17       Impact factor: 5.315

6.  Stereotactic brachytherapy of low-grade cerebral glioma after tumor resection.

Authors:  Bogdana Suchorska; Maximilian Ruge; Harald Treuer; Volker Sturm; Jürgen Voges
Journal:  Neuro Oncol       Date:  2011-08-25       Impact factor: 12.300

Review 7.  Low-grade gliomas: introduction and overview.

Authors:  J M Piepmeier; S Christopher
Journal:  J Neurooncol       Date:  1997-08       Impact factor: 4.130

Review 8.  Controversies concerning the application of brachytherapy in central nervous system tumors.

Authors:  Bo-Lin Liu; Jin-Xiang Cheng; Xiang Zhang; Wei Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2010-02       Impact factor: 4.553

9.  Diagnostic challenges, management and outcomes of midline low-grade gliomas.

Authors:  Mueez Waqar; Shahid Hanif; Nitika Rathi; Kumar Das; Rasheed Zakaria; Andrew R Brodbelt; Carol Walker; Michael D Jenkinson
Journal:  J Neurooncol       Date:  2014-08-06       Impact factor: 4.130

10.  Surgical resection plus stereotactic 125I brachytherapy in adult patients with eloquently located supratentorial WHO grade II glioma - feasibility and outcome of a combined local treatment concept.

Authors:  O Schnell; K Schöller; M Ruge; A Siefert; J-C Tonn; F W Kreth
Journal:  J Neurol       Date:  2008-07-25       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.